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Abstract
Background:  Acne  is  one  of  the  dermatological  pathologies  with  the  highest  incidence  around
the world.  It  is  a  multifactorial  disease  and  its  treatment  can  be  complex.  Propionibacterium
acnes play  a  key  role  in  the  inﬂammation  of  this  dermatosis.  Topical  antibiotics,  including  mainly
erythromycin  and  clindamycin,  have  been  used,  but  there  is  controversy  over  their  use  due  to
the widely  documented  bacterial  resistance.  For  this  reason  a  meta-analysis  of  the  publications
over the  past  10  years  is  presented  in  order  to  conﬁrm  this  hypothesis.
Material  and  methods: A  search  was  made  of  the  publications  over  the  past  10  years
that included  the  results  of  antibiogams  of  patients  with  acne.  MeSH  type  searches  were
performed with  the  terms  ‘‘acne  vulgaris’’,  ‘‘Propionibacterium  acnes’’,  ‘‘topical  admin-
istration’’,  ‘‘treatment’’,  ‘‘erythromycin’’,  ‘‘clindamycin’’,  ‘‘nadiﬂoxacin’’,  ‘‘antibacterial
agent’’,  ‘‘bacterial  drug  resistance’’  in  PubMed,  Ovid,  EBSCO,  Cochrane,  ScienceDirect  and
ClinicalKey  meta-searches.
Results:  A  total  of  13  articles  were  found  that  met  the  inclusion  criteria.  The  mean  odds  ratio
(OR 1.24,  95%  CI)  of  the  articles  showed  a  slight  tendency  towards  resistance  of  P.  acnes.
Conclusions:  An  increase  in  bacterial  resistance  to  topical  erythromycin  and  clindamycin  can
be conﬁrmed,  thus  the  use  of  these  antibiotics  is  recommended  in  selective  cases  for  short
periods,  and  in  combination  with  benzoyl  peroxide  for  the  best  clinical  outcome  in  patients
with acne  vulgaris.
©  2015  Academia  Mexicana  de  Cirug´ıa  A.C.  Published  by  Masson  Doyma  Me´xico  S.A.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/). Please cite this article as: Alvarez-Sánchez M, Rodríguez-Ayala E, Ponce-Olivera RM, Tirado-Sánchez A, Arellano-Mendoza MI. ¿Resistencia
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¿Resistencia  en  el  acné?  Un  metaanálisis  a  propósito  de  la  controversia
Resumen
Antecedentes:  El  acné  es  una  de  las  afecciones  dermatológicas  con  mayor  incidencia  a  nivel
mundial; su  origen  es  multifactorial  y,  por  lo  tanto,  su  tratamiento  puede  ser  complejo.
Propionibacterium  acnes  tiene  un  papel  primordial  en  la  inﬂamación  de  esta  dermatosis  y  para
su tratamiento  se  usan  antibióticos  tópicos;  entre  los  principales  se  encuentran  eritromicina  y
clindamicina,  en  los  que  se  ha  documentado  una  amplia  resistencia  bacteriana,  lo  que  genera
controversia  respecto  a  su  uso.  Por  este  motivo  se  presenta  un  metaanálisis  de  las  publicaciones
de los  últimos  10  an˜os  para  conﬁrmar  esta  hipótesis.
Material  y  métodos: En  la  literatura  de  los  últimos  10  an˜os  se  buscaron  artículos  sobre  resul-
tados de  cultivos  con  antibiograma  de  pacientes  con  acné.  Se  realizaron  búsquedas  tipo
MeSH con  los  términos  «acne  vulgaris», «Propionibacterium  acnes»,  «topical  administration»,
«treatment», «erythromycin»,  «clindamycin»,  «nadiﬂoxacin»,  «antibacterial  agent»,  «bacterial
drug resistance»,  en  los  metabuscadores  PubMed,  Ovid,  EBSCO,  Cochrane,  ScienceDirect  y
ClinicalKey.
Resultados:  Se  encontraron  13  artículos  que  cumplieron  con  los  criterios  de  inclusión.  La  razón
de momios  promedio  (OR  1.24,  IC  95%)  de  los  artículos  demostró  una  ligera  tendencia  hacia  la
resistencia  de  Propionibacterium  acnes.
Conclusiones:  Se  conﬁrma  el  aumento  en  la  resistencia  bacteriana  de  Propionibacterium  acnés
a eritromicina  y  clindamicina  tópica,  por  lo  que  recomendamos  el  uso  de  estos  antibióticos
combinados  en  casos  selectos  por  periodos  cortos  y  en  combinación  con  peróxido  de  benzoilo,
para obtener  el  mejor  resultado  clínico  en  los  pacientes  con  Acne  vulgaris.
© 2015  Academia  Mexicana  de  Cirug´ıa  A.C.  Publicado  por  Masson  Doyma  Me´xico  S.A.  Este  es  un
art´ıculo Open  Access  bajo  la  CC  BY-NC-ND  licencia  (http://creativecommons.org/licencias/by-
nc-nd/4.0/).
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Acne  is  the  second  major  cause  for  dermatology  consul-
tation,  therefore  it  is  important  to  know  how  to  treat
it  appropriately.1 The  treatment  guidelines  for  acne  vul-
garis  establish  as  their  criteria:  (a)  the  clinical  variety  of
acne,  classiﬁed  as  comedonal,  papulo-postular,  nodulocys-
tic  and  (b)  severity.2 The  most  frequently  used  treatment
for  acne,  and  especially  for  papulo-postular  acne,  are
topical  antibiotics.2,3 Because  they  have  been  used  indis-
criminately,  an  increased  resistance  to  topical  antibiotics4
has  been  conﬁrmed  in  Propionibacterium  acnes  (P.  acnes),
by  means  of  cultures  and  antibiograms.5
In  order  to  evaluate  whether  there  is  sufﬁcient  evi-
dence  to  consider  P.  acnes  resistant  to  topical  antibiotics,
we  performed  a  meta-analysis  of  the  articles  published  on
the  subject,  and  our  research  covered  the  last  10  years
(2004--2013).
Material and methods
Search  strategyThe  literature  published  from  1  January  to  31  Decem-
ber  2013  on  the  topical  treatment  was  reviewed.  The
metasearch  engines  we  used  were  PubMed,  Ovid,  EBSCO,
Cochrane,  ScienceDirect  and  ClinicalKey.
m
s
c
ISearches  were  made  using  the  following  MeSH
erms:  ‘‘acne  vulgaris’’,  ‘‘Propionibacterium  acnes’’,
‘topical  administration’’,  ‘‘treatment’’,  ‘‘erythromycin’’,
‘clindamycin’’,  ‘‘nadiﬂoxacin’’,  ‘‘antibacterial  agent’’,
‘bacterial  drug  resistance’’.
election  of  studies
tudies  published  from  1  January  2004  until  31  Decem-
er  2013  (10  years)  and  written  in  English  and/or  Spanish
ere  chosen.  Two  authors  (Alvarez-Sánchez  and  Arellano-
endoza)  independently  reviewed,  assessed  and  chose  the
tudies  for  analysis.
icrobiological  analysis
ata  relating  to  the  method  of  handling  samples,  trans-
ort,  cultures,  isolation  and  identiﬁcation  of  P.  acnes  were
athered  and  the  antibiogram  results  of  the  antibiotics
hat  are  available  for  topical  administration  (clindamycin,
rythromycin  and  nadiﬂoxacin).  They  were  assessed  with
esults  for:  sensitivity  and  resistance,  cut-off  points  of
inimum  inhibitory  concentration  or  E-strip  based  on  the
tandards  of  the  European  Committee  on  Antimicrobial  Sus-
eptibility  Testing  and  the  Clinical  and  Laboratory  Standards
nstitute.6
1D
T
T
t
P
d
s
S
T
s
w
s
i
t
w
R
A
s
2
t
o
o
a
a
e
w
c
r
w
s
c
i
b
s
c
p
0
t
1
r
i
e
a
c
e
S
(
(
2
D
A
p
h
t
i
a
p92  
ata  extraction
he  data  gathered  from  published  studies  were  evaluated.
he  following  information  was  extracted  from  each  study:
otal  number  of  patients,  patients  with  identiﬁcation  of
.  acnes  and  the  abovementioned  microbiological  data.  Any
iscrepancy  between  the  observers  was  resolved  by  consen-
us  or  by  including  a  third  observer.
tatistical  analysis
he  comprehensive  meta-analysis  (CMA  version  2.2.064)
oftware  package  was  used  for  processing  the  data,  the  data
as  entered  and  the  statistical  analysis  made,  which  can  be
een  in  the  forest  plot  (Fig.  1).
The  cut-off  point  for  determining  resistance  or  sensitivity
s  an  odds  ratio  (OR)  of  1,  where  less  than  1  indicates  sensi-
ivity  and  greater  than  1  indicates  resistance;  p-values  <  0.05
ere  considered  statistically  signiﬁcant.
esults
round  501  articles  were  found  in  the  above  mentioned
earch  in  the  period  selected  (January  2004  to  December
013).  We  found  no  duplicated  articles,  and  only  142  of  the
otal  met  the  criteria  of  identifying  P.  acnes, and  the  analysis
f  resistance  and  sensitivity  with  an  antibiogram.  However,
nly  24  studies  were  selected  for  methodological  review  and
nalysis,  leaving  only  13  which  met  all  the  microbiological
nd  clinical  data  to  be  analysed;  the  remaining  studies  were
xcluded  due  to  a  lack  of  data  or  because  their  methodology
as  incomplete  (Fig.  2).
It  was  established  that  13  articles  had  a  classiﬁcation  of
ases  and  controls  with  a  grade  IIIB  level  of  evidence  and
ecommendation,  without  obtaining  the  clinical  trial  level,
hich  is  preferable  for  this  statistical  design  (Table  1).7--19
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The  following  data  were  extracted  from  the  studies  cho-
en:  sample  with  P.  acnes, sensitivity  and  resistance  to
lindamycin  and  erythromycin.  Nadiﬂoxacin  was  not  found
n  any  of  the  publications,  only  levoﬂoxacin  was  tested,
ut  its  administration  route  meant  it  was  ruled  out  for  the
tudy.7
Once  these  data  had  been  selected,  the  odd  ratio  OR  was
alculated  for  each,  and  the  upper  limit  and  the  statistical
 value  in  each  article.
Fig.  1  shows  us  how  the  mean  OR  is  1.24,  with  a  95%  CI  of
.7048--2.3090.  A  total  of  1770  patients  was  obtained  from
he  13  articles,  with  a  range  from  40  to  400  and  a  mean  of
36.15;  P.  acnes  was  identiﬁed  in  70%  of  the  patients  and
esistance  to  treatment  demonstrated  in  43%,  with  sensitiv-
ty  in  57%.  Most  of  the  articles  were  from  different  countries,
xcept  2  from  Chile  (Schafer  et  al.12 and  Gübelin  et  al.14)
nd  2  from  Korea  (Moon  et  al.8 and  Song  et  al.17).  The  other
ountries  were:  México7 (González  et  al.),  Japan9 (Ishida
t  al.),  China10 (Luk  et  al.),  France11 (Dumont-Wallon  et  al.),
weden13 (Oprica  et  al.),  Singapore15 (Tan  et  al.),  Iran16
Zandi  et  al.),  Colombia18 (Mendoza  et  al.)  and  Turkey19
Ergin  et  al.).  The  greatest  resistance  was  observed  between
010  and  2012  (Table  1).
iscussion
cne  is  a  frequent  reason  for  consultation  in  our  clinical
ractice.1 In  recent  years  resistance  to  topical  antibiotics
as  become  evident  in  various  publications,  principally  to
opical  erythromycin  and  clindamycin.4 However,  in  practice
ts  clinical  signiﬁcance  has  not  been  fully  clariﬁed  and  they
re  still  used  in  routine  practice  to  manage  these  patients,
rincipally  for  patients  with  papulo-postular  acne.  In  our
eview  of  the  literature,  we  observed  that  there  are  few
ublications  containing  strict  criteria  for  demonstrating  the
esistance  of  P.  acnes  to  topical  antibiotics;  7  articles  pre-
ented  an  OR  greater  than  1,  which  shows  a  tendency  to
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 of  each  study.
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501 articles
found in the
database
142 met the
greater
inclusion
criteria
13 articles
remaining in the
final selection 
Without duplicates
Articles excluded: 1 article identifies
P. acnes, but did not perform an individual
antibiogram; 3 only mention a history of
resistance, 1 > 10 years, 1 mentions
resistance but does not indicate taking
samples in patients with acne, 2 refer to
resistance, history and creation of a biofilm,
3 refer to resistance and type of skin sample,
they perform an antibiogram, do not mention
resistance percentages and perform a
genome sequence.  
359 did not
meet the
inclusion
criteria
24 articles were
subjected to
methodological
review
118 describe resistance
and review the subject.
They did not specify
the methodology
Figure  2  Process  for  selecting  the  articles.
Table  1  Selected  studies.
Authors Country Year Sample
total
Samples
with
P. acnes
Resistant Sensitive Resistance
percentage
Sensitivity
percentage
ERY
percentage
CLN
percentage
Schafer et al.12 Chile 2013 83 80 27 53 33.8 66.3 12.50 7.50
Mendoza et al.18 Colombia 2013 100 100 40 60 40.0 60.0 35.00 15.00
Luk et al.10 China 2013 111 86 47 39 54.7 45.3 20.90 53.50
Moon et al.8 Korea 2012 100 30 11 19 36.7 63.3 26.70 30.00
Song et al.17 Korea 2011 46 31 1 30 3.2 96.8 0.00 3.22
Zandi et al.16 Iran 2011 100 57 30 27 52.6 47.4 12.10 10.30
Dumont-Wallon
et al.11
France 2010 273 273 205 68 75.1 24.9 73.60 NA
González et al.7 Mexico 2010 49 49 37 12 75.5 24.5 46.00 36.00
Ishida et al.9 Japan 2008 73 48 18 30 37.5 62.5 10.40 8.30
Tan et al.15 Singapore 2007 262 174 26 148 14.9 85.1 52.00 50.00
Gübelin et al.14 Chile 2006 53 53 4 49 7.5 92.5 69.20 50.00
Ergin et al.19 Turkey 2006 120 53 18 35 34.0 66.0 18.00 15.00
Oprica et al.13 Sweden 2004 400 201 69 132 34.3 65.7 19.90 27.30
Total 1770 1235 533 702 38.4 61.6 30.48 25.51
CLN: clindamycin; ERY: erythromycin; NA: not assigned; P. acnes: Propionibacterium acnes.
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194  
acterial  resistance.  We  also  found  2  studies  which  pre-
ented  excellent  sensitivity  to  antibiotics.14,17 In  Song  et  al.
tudy17 of  31  samples  diagnosed  with  P.  acnes, only  one  iso-
ate  was  resistant  to  clindamycin,  which  moves  the  general
ean  of  the  studies  towards  sensitivity,  and  this  is  also
emonstrated  with  the  above  mentioned  analysis  in  all  of
he  patients.
Erythromycin  and  clindamycin  are  the  2  topical  antibi-
tics  which  all  the  articles  tested.  In  the  case  of
rythromycin,  the  mean  resistance  percentage  in  all  the
ublications  is  30%,  with  a  maximum  of  73.6%  in  Dumont-
allon  et  al.  study11 and  nil  resistance  Song  et  al.  study.17
he  case  of  clindamycin  is  similar,  with  a  resistance  mean
f  25.5%  and  a  maximum  of  53%  in  Luk  et  al.  study10
ith  a  minimum  of  3%  in  the  aforementioned  study  by
ong  et  al.17
We  should  highlight  that  despite  the  fact  that  there  is
 statistical  tendency  towards  bacterial  resistance,  it  is
ery  weak  and  clinically  the  topical  treatment  might  fail;
owever  it  should  be  remembered  that  the  combination  of
opical  antibiotics  with  benzoyl  peroxide,  as  indicated  in  the
reatment  guidelines,  reduces  the  incidence  of  resistance.
ecent  publications  conﬁrm  that  patients  with  resistant  P.
cnes  have  a  clinical  beneﬁt  if  the  area  is  washed  with
enzoyl  peroxide  at  6%  for  20  s  before  treatment  with  the
opical  antibiotic,  this  reduces  bacterial  resistance  consid-
rably  (1  log  after  one  week’s  treatment  and  at  least  2  log
fter  3  weeks  of  treatment).20 In  our  country,  the  commer-
ial  presentation  of  benzoyl  peroxide  at  5%  can  be  found
n  combination  with  topical  antibiotics,  which  helps  der-
atologists  to  achieve  a  good  therapeutic  response  in  their
atients.
We  observed  that  there  are  few  studies  that  would
ave  made  cultures  of  P.  acnes, and  those  available  had
n  evidence  grade  IIIB,  therefore  it  is  imperative  to  per-
orm  more  rigorous  clinical--microbiological  studies  with
cientiﬁc  evidence  for  a  highly  prevalent  disease  like  acne
ulgaris.
The  resistance  indices  observed  in  the  studies  might  be
ower,  when  short  courses  of  antibiotics  were  used  and  in
ombination  with  benzoyl  peroxide.
In  conclusion,  a  tendency  towards  P.  acnes  bacterial
esistance  has  been  found  in  patients  with  acne  vulgaris.
onotherapy  using  clindamycin  and  erythromycin  should
ot  be  the  basis  for  treatment  of  this  condition;  these
opical  antibiotics  can  be  used  in  very  select  cases,  for
hort  periods,  and  should  always  be  used  in  combination
ith  benzoyl  peroxide  to  diminish,  reduce  inﬂammation
nd  avoid  P.  acnes  bacterial  resistance  in  patients  with
cne  vulgaris.
We  recommend  that  clinicians  should  use  the  evidence
ound  in  this  meta-analysis  in  order  to  select  the  best  treat-
ent  and  obtain  the  best  results  for  their  patients  with  acne
ulgaris.onﬂict of interests
he  authors  have  no  conﬂict  of  interest  to  declare.
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